Arvate, H. R. Major Clinical Outcomes of the Action of the Co-Agonist Tirzepatide to Liraglutide and Semaglutide in the Treatment of Obesity and Type 2 Diabetes Mellitus: A Systematic Review. IJN 2025, 18.